Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001846487-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $74.00 | -417 | 103.5K | -0.4% | -$30.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 417 | $74.00 | 103,508 | D | — | — |